Shopping Cart 0
Cart Subtotal
AED 0

U.S. Skin Graft Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 9175

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 11744
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

U.S. skin graft market is expected to reach USD 522.52 million by 2025 from USD 293.00 million in 2017, at a CAGR of 7.6% in the forecast period 2018 to 2025.

The major factors driving the growth of this market are increasing number of burns injuries, pressure ulcers and skin infections, developments in skin grafting techniques and technological advances in dermatomes are boosting the growth of the U.S. skin graft market.

The key market players for U.S. skin graft market are listed below:

Integra Lifesciences Corporation

Organogenesis, Inc.

Zimmer Biomet, Inc.

B. Braun Melsungen AG

Nouvag AG

DE Soutter Medical Limited

Surtex Instruments Limited

Exsurco Medical, Inc.

The market is further segmented into:

Type

Graft Thickness

Application

Equipment Type

End-user

The U.S. skin graft market is segmented on the basis of type, graft thickness, application, equipment type, and end-user. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

The U.S. skin graft market is segmented based on type into autologous, allogeneic, xenogeneic, prosthetic and isogeneic. In 2018, autologous is expected to dominate the U.S. skin graft market with 38.5% market share and is expected to reach USD 207.25 million by 2025, growing at the highest CAGR of 8.1% in the forecast period of 2018 to 2025.

The U.S. skin graft market is segmented based on graft thickness into split-thickness, full-thickness, and composite graft. In 2018, split-thickness is expected to dominate the U.S. skin graft market with 47.9% market share and is expected to reach USD 254.38 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.

The U.S. skin graft market is segmented based on application into burns, extensive wound, skin cancer, and extensive skin loss due to infection. In 2018, burns is expected to dominate the U.S. skin graft market with 46.7% market share and is expected to reach USD 251.53 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.

The U.S. skin graft market is segmented based on equipment type into dermatome, general surgical instruments, consumables, and others. In 2018, dermatome is expected to dominate the U.S. Skin graft market with 43.7% market share and is expected to reach USD 235.29 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.

Dermatome is further sub-segmented into electrical dermatomes, air-powdered dermatomes, knife dermatomes, and drum dermatomes. In 2018, electrical dermatomes is expected to dominate the U.S. Skin graft market with 47.6% market share and is expected to reach USD 115.88 million by 2025, growing at the highest CAGR of 8.6% in the forecast period 2018 to 2025.

Knife dermatome is further sub-segmented into Watson Knife, Cobbett Knife, and Blair/Brown Knife. In 2018, Watson Knife is expected to dominate the U.S. skin graft market with 53.9% market share and is expected to reach USD 63.51 million by 2025, growing at the highest CAGR of 8.8% in the forecast period 2018 to 2025.

Drum dermatome is further sub-segmented into Padgett Dermatomes, and Reese Dermatomes. In 2018, Padgett Dermatomes is expected to dominate the U.S. skin grafts market with 61.5% market share and is expected to reach USD 317.01 million by 2025, with a CAGR of 7.4% in the forecast period 2018 to 2025. However, Reese Dermatomes is expected to grow at the highest CAGR of 7.9% in the forecast period, to reach USD 205.51 million by 2025 from USD 112.51 million in 2017 in the forecast period 2018 to 2025.

The U.S. skin graft market is segmented on the basis of end users into ambulatory surgical centers, hospitals, and dermatology clinics. In 2018, ambulatory surgical centers is expected to dominate the U.S. skin graft market with 53.2% market share and is expected to reach USD 282.82 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.

Covered in this report

The report covers the present scenario and the growth prospects of the U.S. skin graft market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1. Introduction 11

1.1. Objectives Of The Study 11

1.2. Market Definition 11

1.3. Overview Of U.S. Skin Graft Market 11

1.4. Currency And Pricing 12

1.5. Limitation 12

1.6. Markets Covered 13

2. Market Segmentation 14

2.1. Markets Covered 14

2.2. Years Considered For The Study 15

2.3. Currency And Pricing 15

2.4. Research Methodology 16

2.5. Primary Interviews With Key Opinion Leaders 19

2.6. Secondary Sources 20

2.7. Assumptions 20

3. Market Overview 21

3.1. Drivers 23

3.1.1. Increasing Number Of Burns Injuries, Pressure Ulcers, And Skin Infections 23

3.1.2. Technological Advancements And Developments In Skin Grafting Techniques 24

3.1.3. Favorable Reimbursement Policies For Skin Grafting Procedure 25

3.2. Restraints 26

3.2.1. Side Effects Related To The Skin Graft Procedure 26

3.3. Opportunities 27

3.3.1. Increasing Medical Tourisms 27

3.4. Challenges 28

3.4.1. Competition Among Major Players In The U.S. 28

4. Executive Summary 29

5. Premium Insights 31

6. U.S. Skin Graft Market, By Type 33

6.1. Overview 34

6.2. Autologous 35

6.3. Isogeneic 36

6.4. Allogeneic 36

6.5. Xenogeneic 36

6.6. Prosthetic 37

7. U.S. Skin Graft Market, By Graft Thickness 38

7.1. Overview 39

7.2. Split-Thickness 41

7.3. Full-Thickness 41

7.4. Composite Graft 41

8. U.S. Skin Graft Market, By Application 42

8.1. Overview 43

8.2. Extensive Wound 45

8.3. Extensive Skin Loss Due To Infection 45

8.4. Skin Cancer 46

8.5. Burns 46

9. U.S. Skin Graft Market, By Equipment Type 47

9.1. Overview 48

9.2. Dermatome 49

9.2.1. Knife Dermatomes 50

9.2.1.1. Blair/Brown Knife 51

9.2.1.2. Watson Knife 51

9.2.1.3. Cobbett Knife 52

9.2.2. Drum Dermatomes 52

9.2.2.1. Padgett Dermatomes 53

9.2.2.2. Reese Dermatomes 53

9.2.3. Electrical Dermatomes 53

9.2.4. Air-Powdered Dermatomes 54

9.3. General Surgical Instruments 55

9.4. Consumables 55

9.5. Others 55

10. U.S. Skin Graft Market, By End User 56

10.1. Overview 57

10.2. Hospitals 59

10.3. Dermatology Clinics 59

10.4. Ambulatory Surgical Centers 59

11. U.S. Skin Graft Market, Company Landscape 60

11.1. Company Share Analysis: North America 60

12. Company Profiles 61

12.1. Organogenesis Inc. 61

12.1.1. Company Overview 61

12.1.2. Organogenesis Inc.: Company Snapshot 61

12.1.3. Product Portfolio 62

12.1.4. Recent Developments 62

12.2. Integra Lifesciences Corporation 63

12.2.1. Company Overview 63

12.2.2. Integra Lifesciences Corporation: Revenue Analysis 63

12.2.3. Product Portfolio 64

12.2.4. Recent Developments 65

12.3. Zimmer Biomet 66

12.3.1. Company Overview 66

12.3.2. Zimmer Biomet: Revenue Analysis 66

12.3.3. Product Portfolio 67

12.3.4. Recent Developments 67

12.4. B. Braun Melsungen Ag 68

12.4.1. Company Overview 68

12.4.2. B. Braun Melsungen Ag: Revenue Analysis 68

12.4.3. Product Portfolio 69

12.4.4. Recent Developments 69

12.5. Avita Medical 70

12.5.1. Company Overview 70

12.5.2. Avita Medical :Revenue Analysis 70

12.5.3. Product Portfolio 71

12.5.4. Recent Developments 71

12.6. De Soutter Medical 72

12.6.1. Company Overview 72

12.6.2. De Soutter Medical: Company Snapshot 72

12.6.3. Product Portfolio 73

12.6.4. Recent Developments 73

12.7. Exsurco Medical, Inc. 74

12.7.1. Company Overview 74

12.7.2. Exsurco Medical, Inc.:Company Snapshot 74

12.7.3. Product Portfolio 75

12.7.4. Recent Developments 75

12.8. Mallinckrodt 76

12.8.1. Company Overview 76

12.8.2. Mallinckrodt: Revenue Analysis 76

12.8.3. Product Pipeline 77

12.8.4. Recent Developments 77

12.9. Nouvag 78

12.9.1. Company Overview 78

12.9.2. Nouvag: Company Snapshot 78

12.9.3. Product Portfolio 79

12.9.4. Recent Developments 79

12.10. Surtex Instruments Limited 80

12.10.1. Company Overview 80

12.10.2. Surtex Instruments Limited: Company Snapshot 80

12.10.3. Product Portfolio 81

12.10.4. Recent Developments 81

12.11. Tissue Regenix 82

12.11.1. Company Overview 82

12.11.2. Tissue Regenix: Revenue Analysis 82

12.11.3. Product Portfolio 83

12.11.4. Recent Developments 83

13. Related Reports 84


List Of Figure

Figures List

Figure 1 U.S. Skin Graft Market : Segmentation 14

Figure 2 U.S. Skin Graft Market: Data Triangulation 16

Figure 3 U.S. Skin Graft Market: Research Snapshot 17

Figure 4 U.S. Skin Graft Market : Bottom Up Approach 18

Figure 5 U.S. Skin Graft Market : Top Down Approach 18

Figure 6 U.S. Skin Graft Market: Interview Demographics 19

Figure 7 Drivers, Restraints, Opportunities, And Challenges In

U.S. Skin Graft Market 22

Figure 8 U.S. Skin Graftmarket: Segmentation 30

Figure 9 Increasing Number Of Burns Injuries, Pressure Ulcers, Skin Infections, And Developments In Skin Grafting Techniques Are Expected To Drive The Market For U.S. Skin Graft In The Forecast Period 2018 To 2025 31

Figure 10 Autologous Segment Is Expected To Account For The Largest Share Of The U.S. Skin Graft Market In 2018 & 2025 32

Figure 11 U.S. Skin Graft Market: By Type, 2017 34

Figure 12 U.S. Skin Graft Market: By Graft Thickness, 2017 39

Figure 13 U.S. Skin Graft Market: By Application, 2017 43

Figure 14 U.S. Skin Graft Market: By Equipment Type, 2017 48

Figure 15 U.S. Skin Graft Market: By End User, 2017 57

Figure 16 U.S. Skin Graft Market: Company Share 2017 (%) 60


List Of Table

Table 1 Few Cpt Codes For Skin Graft Procedures 25

Table 2 Percentage Of Cost Saving In Various Countries Due To Medical Tourism 27

Table 3 Stsg Produre Number In U.S. (2015- 2025) 36

Table 4 U.S. Skin Graft Market, By Type, 2016-2025 (Usd Million) 39

Table 5 U.K. Skin Graft Market, By Type, 2016-2025 (Usd Million) 40

Table 6 Canada Skin Graft Market, By Type, 2016-2025 (Usd Million) 41

Table 7 U.S. Skin Graft Market, By Graft Thickness, 2016-2025 (Usd Million) 46

Table 8 U.K. Skin Graft Market, By Graft Thickness, 2016-2025 (Usd Million) 47

Table 9 Canada Skin Graft Market, By Graft Thickness, 2016-2025 (Usd Million) 48

Table 10 U.S. Skin Graft Market, By Application, 2016-2025 (Usd Million) 52

Table 11 U.K. Skin Graft Market, By Application, 2016-2025 (Usd Million) 53

Table 12 Canada Skin Graft Market, By Application, 2016-2025 (Usd Million) 54

Table 13 U.S. Skin Graft Market, By Equipment Type, 2016-2025 (Usd Million) 59

Table 14 U.K. Skin Graft Market, By Equipment Type, 2016-2025 (Usd Million) 60

Table 15 Canada Skin Graft Market, By Equipment Type, 2016-2025 (Usd Million) 61

Table 16 U.S. Dermatome Market, By Equipment Type, 2016-2025 (Usd Million) 63

Table 17 U.K. Dermatome Market, By Equipment Type, 2016-2025 (Usd Million) 63

Table 18 Canada Dermatome Market, By Equipment Type, 2016-2025 (Usd Million) 64

Table 19 U.S. Knife Dermatome Market, By Equipment Type,2016-2025 (Usd Million) 65

Table 20 U.K. Knife Dermatome Market, By Equipment Type,2016-2025 (Usd Million) 65

Table 21 Canada Knife Dermatomes Market, By Equipment Type,2016-2025 (Usd Million) 66

Table 22 U.S. Drum Dermatome Market, By Equipment Type,2016-2025 (Usd Million) 68

Table 23 U.K. Drum Dermatome Market, By Equipment Type,2016-2025 (Usd Million) 68

Table 24 Canada Drum Dermatomes Market, By Equipment Type,2016-2025 (Usd Million) 69

Table 25 U.S. Skin Graft Market, By End User, 2016-2025 (Usd Million) 75

Table 26 U.K. Skin Graft Market, By End User, 2016-2025 (Usd Million) 75

Table 27 Canada Skin Graft Market, By End User, 2016-2025 (Usd Million) 76

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Integra Lifesciences Corporation

Organogenesis, Inc.

Zimmer Biomet, Inc.

B. Braun Melsungen AG

Nouvag AG

DE Soutter Medical Limited

Surtex Instruments Limited

Exsurco Medical, Inc.